Jv. Campellone et al., FATAL OUTCOME FROM NEUROLEPTIC MALIGNANT SYNDROME-ASSOCIATED WITH CLOZAPINE, Neuropsychiatry, neuropsychology, and behavioral neurology, 8(1), 1995, pp. 70-73
The association between clozapine and neuroleptic malignant syndrome (
NMS) is not clear, in part because of the small number of reported cas
es and of the concurrent use of other drugs in some instances. We desc
ribe a man who developed NMS associated with the use of clozapine and
valproic acid. This case provides further evidence that clozapine is a
ssociated with NMS, despite being associated with fewer extrapyramidal
side effects than many other antipsychotics. The patient ultimately e
xpired, emphasizing that NMS can be lethal regardless of the inciting
agent. To the best of our knowledge, his death represents the first re
ported fatality from clozapine-associated NMS.